• 2022
  Benotmane I, Bruel T, Planas D, Fafi-Kremer S, Schwartz O, Caillard S, , A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients., Kidney Int 2022 05; 101(5): 1073-1076.
• 2022
  Simon-Loriere E, Schwartz O, , Towards SARS-CoV-2 serotypes?, Nat Rev Microbiol 2022 04; 20(4): 187-188.
• 2022
  Morel A, Imbeaud S, Scemla A, Péré H, Fourgeaud J, Amrouche L, Robillard N, Planas D, Puech J, Simon S, Lanternier F, Bélec L, Zuber J, Schwartz O, Anglicheau D, Chavarot N, Veyer D, , Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab., Am J Transplant 2022 Feb; (): .
• 2022
  Henriquez S, Zerbit J, Bruel T, Ouedrani A, Planas D, Deschamps P, Staropoli I, Hadjadj J, Varet B, Ermak N, Bouscary D, Willems L, Fouquet G, Decroocq J, Franchi P, Deau-Fischer B, Terrier B, Tamburini J, Chatenoud L, Schwartz O, Vignon M, , Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma., Blood 2022 02; 139(6): 942-946.
• 2022
  Spencer DA, Goldberg BS, Pandey S, Ordonez T, Dufloo J, Barnette P, Sutton WF, Henderson H, Agnor R, Gao L, Bruel T, Schwartz O, Haigwood NL, Ackerman ME, Hessell AJ, , Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis., Nat Commun 2022 02; 13(1): 662.
• 2022
  Planas D, Saunders N, Maes P, Guivel-Benhassine F, Planchais C, Buchrieser J, Bolland WH, Porrot F, Staropoli I, Lemoine F, Péré H, Veyer D, Puech J, Rodary J, Baele G, Dellicour S, Raymenants J, Gorissen S, Geenen C, Vanmechelen B, Wawina-Bokalanga T, Martí-Carreras J, Cuypers L, Sève A, Hocqueloux L, Prazuck T, Rey FA, Simon-Loriere E, Bruel T, Mouquet H, André E, Schwartz O, , Considerable escape of SARS-CoV-2 Omicron to antibody neutralization., Nature 2022 02; 602(7898): 671-675.
• 2022
  Boudhabhay I, Serris A, Servais A, Planas D, Hummel A, Guery B, Parize P, Aguilar C, Dao M, Rouzaud C, Ferriere E, Knebelmann B, Sakhi H, Leruez M, Joly D, Schwartz O, Lanternier F, Bruel T, , COVID-19 outbreak in vaccinated patients from a hemodialysis unit: antibody titers as a marker of protection from infection., Nephrol Dial Transplant 2022 Feb; (): .
• 2022
  Vila IK, Chamma H, Steer A, Saccas M, Taffoni C, Turtoi E, Reinert LS, Hussain S, Marines J, Jin L, Bonnefont X, Hubert M, Schwartz O, Paludan SR, Van Simaeys G, Doumont G, Sobhian B, Vlachakis D, Turtoi A, Laguette N, , STING orchestrates the crosstalk between polyunsaturated fatty acid metabolism and inflammatory responses., Cell Metab 2022 01; 34(1): 125-139.e8.
• 2022
  Gallais F, Gantner P, Planas D, Solis M, Bruel T, Pierre F, Soulier E, Rossolillo P, Fourati S, Sibilia J, Schwartz O, Fafi-Kremer S, , Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine., Front Immunol 2022 ; 13(): 790212.
• 2021
  Goldberg BS, Kaku CI, Dufloo J, Bruel T, Schwartz O, Spencer DA, Hessell AJ, Ackerman ME, , Revisiting an IgG Fc Loss-of-Function Experiment: the Role of Complement in HIV Broadly Neutralizing Antibody b12 Activity., mBio 2021 10; 12(5): e0174321.
• 2021
  Betton M, Livrozet M, Planas D, Fayol A, Monel B, Védie B, Bruel T, Tartour E, Robillard N, Manuguerra JC, Blanchard A, Ghosn J, Visseaux B, Péré H, Lebeaux D, Schwartz O, Veyer D, Hulot JS, , , Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019., Clin Infect Dis 2021 09; 73(6): e1337-e1344.
• 2021
  Marlin R, Godot V, Cardinaud S, Galhaut M, Coleon S, Zurawski S, Dereuddre-Bosquet N, Cavarelli M, Gallouët AS, Maisonnasse P, Dupaty L, Fenwick C, Naninck T, Lemaitre J, Gomez-Pacheco M, Kahlaoui N, Contreras V, Relouzat F, Fang RHT, Wang Z, Ellis J, Chapon C, Centlivre M, Wiedemann A, Lacabaratz C, Surenaud M, Szurgot I, Liljeström P, Planas D, Bruel T, Schwartz O, Werf SV, Pantaleo G, Prague M, Thiébaut R, Zurawski G, Lévy Y, Grand RL, , Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques., Nat Commun 2021 09; 12(1): 5215.
• 2021
  Gallais F, Gantner P, Bruel T, Velay A, Planas D, Wendling MJ, Bayer S, Solis M, Laugel E, Reix N, Schneider A, Glady L, Panaget B, Collongues N, Partisani M, Lessinger JM, Fontanet A, Rey D, Hansmann Y, Kling-Pillitteri L, Schwartz O, De Sèze J, Meyer N, Gonzalez M, Schmidt-Mutter C, Fafi-Kremer S, , Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection., EBioMedicine 2021 Sep; 71(): 103561.
• 2020
  Staropoli I, Dufloo J, Ducher A, Commere PH, Sartori-Rupp A, Novault S, Bruel T, Lorin V, Mouquet H, Schwartz O, Casartelli N, , Flow Cytometry Analysis of HIV-1 Env Conformations at the Surface of Infected Cells and Virions: Role of Nef, CD4, and SERINC5., J Virol 2020 02; 94(6): .
• 2020
  Le Hingrat Q, Visseaux B, Bertine M, Chauveau L, Schwartz O, Collin F, Damond F, Matheron S, Descamps D, Charpentier C, , Genetic variability of Long Terminal Repeat region between HIV-2 groups impacts transcriptional activity, J. Virol. 2020 Jan;.
• 2020
  Labeau A, Simon-Loriere E, Hafirassou ML, Bonnet-Madin L, Tessier S, Zamborlini A, Dupré T, Seta N, Schwartz O, Chaix ML, Delaugerre C, Amara A, Meertens L, A genome-wide CRISPR-Cas9 screen identifies the dolichol-phosphate mannose synthase complex as a host dependency factor for dengue virus infection, J. Virol. 2020 Jan;.
• 2019
  Passos V, Zillinger T, Casartelli N, Wachs AS, Xu S, Malassa A, Steppich K, Schilling H, Franz S, Todt D, Steinmann E, Sutter K, Dittmer U, Bohne J, Schwartz O, Barchet W, Goffinet C, Characterization of Endogenous SERINC5 Protein as Anti-HIV-1 Factor, J. Virol. 2019 Dec;93(24).
• 2019
  Pinto D, Fenwick C, Caillat C, Silacci C, Guseva S, Dehez F, Chipot C, Barbieri S, Minola A, Jarrossay D, Tomaras GD, Shen X, Riva A, Tarkowski M, Schwartz O, Bruel T, Dufloo J, Seaman MS, Montefiori DC, Lanzavecchia A, Corti D, Pantaleo G, Weissenhorn W, Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01, Cell Host Microbe 2019 11;26(5):623-637.e8.
• 2016
  Lahouassa H, Blondot ML, Chauveau L, Chougui G, Morel M, Leduc M, Guillonneau F, Ramirez BC, Schwartz O, Margottin-Goguet F, HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages, Proc. Natl. Acad. Sci. U.S.A. 2016 Apr;.
• 1996
  Conio M, Caroli-Bosc F, Maes B, Pugliese V, Demarquay JF, Dumas R, Bellon S, Delmont J, , Early migration of a covered self-expanding metal stent corrected by implantation of a second stent., Am J Gastroenterol 1996 Oct; 91(10): 2212-4.